USE OF LACTOBACILLUS FERMENTUM U-21 STRAIN CELLS FOR PREVENTION OF PATHOLOGIC TISSUE CHANGE CAUSED BY OXIDATIVE STRESS Russian patent published in 2021 - IPC A61K35/744 A61K35/747 A61P1/16 A61P9/00 A61P11/00 A61P13/12 A61P25/16 A61P25/28 

FIELD: pharmaceutics.

SUBSTANCE: invention relates to the pharmaceutical industry, namely to use of the Limosilactobacillus fermentum U-21 strain cell culture. Use of a cell culture of the Limosilactobacillus fermentum U-21 strain, filed by RNCIM under the number B-12075, in an effective amount for prevention and elimination of pathological changes caused by the oxidative stress in vital organs and tissues, namely in the liver, lungs, brain and nerve tissue.

EFFECT: described application allows reducing the level of tissue and organ cell damage, especially in nerve tissue.

4 cl, 2 dwg, 4 tbl, 4 ex